Colbeck Capital to Attend Pension Bridge Private Credit 2025

NEW YORK--(BUSINESS WIRE)-- Colbeck Capital Management, a leading middle-market private credit firm focused on strategic lending, is pleased to share that Greg Budetti, Head of Business Development, is attending Pension Bridge Private Credit. The event, to be held February 11-12 at the Park Hyatt Aviara in Carlsbad, California, will gather North America’s leading institutional investors, consultants, and managers for a variety of in-depth discussions, interactive panel sessions and dedicated networking opportunities.

This year’s programming will unpack key takeaways from 2024 as well as priorities for the year ahead in direct lending, asset-based finance, NAV lending, and royalties, among others. Through the event’s strategically curated 2:1 investor to manager ratio, attendees are able to engage in conversations aimed to facilitate dealmaking and institutional allocation opportunities. To learn more about Pension Bridge Private Credit, please click here.

About Colbeck Capital Management

Colbeck Capital Management (colbeck.com) is a leading, middle-market private credit manager focused on strategic lending. Colbeck originates senior secured loans to companies going through periods of transition, providing creative capital solutions. Colbeck sponsors its portfolio companies through consistent engagement with management teams in areas such as finance, capital markets and growth strategies, distinguishing itself from traditional lenders. Colbeck was founded in 2009 by Jason Colodne and Jason Beckman and currently manages $3+ billion of invested and committed capital. Colbeck’s principals have extensive experience investing through different market cycles at leading institutions, including Goldman Sachs and Morgan Stanley.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250210345674/en/

Media Contacts
Jonathan Warren/Jared Kimmel
Gasthalter & Co.
(212) 257-4170
[email protected]

Source: Colbeck Capital Management

You May Also Be Interested In

• Merck and Moderna Announce Phase 3 INTerpath-001 Trial of Intismeran Autogene Plus KEYTRUDA® Met Endpoints of Recurrence-Free Survival (RFS) and Distant Metastasis-Free Survival (DMFS) in Patients Wi
• Leatherneck Tree Service Strengthens Community Ties Through Local Property Safety Initiatives.
• Toobit Opens TIFT 2026 Team and Solo Championships